Dr Michael J. Miller joins Spore.Bio as VP of Scientific and Regulatory Affairs0 SHARESPosted: 29 January 2026 | Dominic Tyer (European Pharmaceutical Review) |The French start-up focuses on advancing rapid microbiology in manufacturing quality control. Spore.Bio has appointed Dr Michael J. Miller (pictured above right) as its VP of Scientific and Regulatory Affairs as it seeks to embed rapid, modern microbiology in pharma manufacturing and other highly regulated industries. An internationally recognised expert in rapid microbiological methods and contamination control, Dr Miller has nearly 40 years of experience in pharmaceutical microbiology, contamination control and the validation of rapid microbiological methods. “The combination of AI, biophotonics and microbiology Spore.Bio is building has the potential to redefine what ‘rapid methods’ mean. 33 – created to establish industry-wide criteria on what constitutes an acceptable alternative or rapid microbiology test.